{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:55:20Z","timestamp":1782572120710,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R56-A3126"],"award-info":[{"award-number":["R56-A3126"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IMK foundation","award":["None"],"award-info":[{"award-number":["None"]}]},{"DOI":"10.13039\/501100004196","name":"Odense Universitetshospital","doi-asserted-by":"publisher","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/501100004196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00520-018-4623-1","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T09:55:33Z","timestamp":1546595733000},"page":"3071-3080","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The nature of nausea: prevalence, etiology, and treatment in patients with advanced cancer not receiving antineoplastic treatment"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4831-2586","authenticated-orcid":false,"given":"Signe","family":"Harder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rn","family":"Herrstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Isaksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Asbjoern","family":"Neergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Frandsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarl","family":"Sigaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Mondrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodil Abild","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mogens","family":"Groenvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"issue":"9","key":"4623_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1200\/JCO.2010.30.7173","volume":"29","author":"H Seow","year":"2011","unstructured":"Seow H, Barbera L, Sutradhar R, Howell D, Dudgeon D, Atzema C, Liu Y, Husain A, Sussman J, Earle C (2011) Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. J Clin Oncol 29(9):1151\u20131158","journal-title":"J Clin Oncol"},{"issue":"2","key":"4623_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/1049909111410965","volume":"29","author":"J Kirkova","year":"2012","unstructured":"Kirkova J, Rybicki L, Walsh D, Aktas A (2012) Symptom prevalence in advanced cancer: age, gender, and performance status interactions. Am J Hosp Palliat Care 29(2):139\u2013145","journal-title":"Am J Hosp Palliat Care"},{"issue":"2","key":"4623_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4103\/0973-1075.179601","volume":"22","author":"M Gupta","year":"2016","unstructured":"Gupta M, Sahi MS, Bhargava A, Talwar V (2016) A prospective evaluation of symptom prevalence and overall symptom burden among cohort of critically ill cancer patients. Indian J Palliat Care 22(2):118\u2013124","journal-title":"Indian J Palliat Care"},{"key":"4623_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1477-7525-8-104","volume":"8","author":"EA Laugsand","year":"2010","unstructured":"Laugsand EA, Sprangers MA, Bjordal K, Skorpen F, Kaasa S, Klepstad P (2010) Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes 8:104","journal-title":"Health Qual Life Outcomes"},{"key":"4623_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-684X-7-16","volume":"7","author":"KR Sigurdardottir","year":"2008","unstructured":"Sigurdardottir KR, Haugen DF (2008) Prevalence of distressing symptoms in hospitalised patients on medical wards: a cross-sectional study. BMC Palliat Care 7:16","journal-title":"BMC Palliat Care"},{"issue":"1","key":"4623_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/082585979100700102","volume":"7","author":"R Fainsinger","year":"1991","unstructured":"Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachern T (1991) Symptom control during the last week of life on a palliative care unit. J Palliat Care 7(1):5\u201311","journal-title":"J Palliat Care"},{"issue":"5","key":"4623_CR7","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s00520-015-3034-9","volume":"24","author":"MO Delgado-Guay","year":"2016","unstructured":"Delgado-Guay MO, Rodriguez-Nunez A, Shin SH, Chisholm G, Williams J, Frisbee-Hume S, Bruera E (2016) Characteristics and outcomes of patients with advanced cancer evaluated by a palliative care team at an emergency center. A retrospective study. Support Care Cancer 24(5):2287\u20132295","journal-title":"Support Care Cancer"},{"issue":"1","key":"4623_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jpainsymman.2010.10.266","volume":"42","author":"A Jimenez","year":"2011","unstructured":"Jimenez A, Madero R, Alonso A, Martinez-Marin V, Vilches Y, Martinez B et al (2011) Symptom clusters in advanced cancer. J Pain Symptom Manag 42(1):24\u201331","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"4623_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0885-3924(96)00042-5","volume":"12","author":"A Vainio","year":"1996","unstructured":"Vainio A, Auvinen A (1996) Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. J Pain Symptom Manag 12(1):3\u201310","journal-title":"J Pain Symptom Manag"},{"key":"4623_CR10","doi-asserted-by":"crossref","unstructured":"Harder SL, Groenvold M, Herrstedt J, Johnsen AT (2019) Nausea in advanced cancer: relationships between intensity, burden, and the need for help. Support Care Cancer 27(1):265\u2013273","DOI":"10.1007\/s00520-018-4326-7"},{"issue":"3","key":"4623_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s005200050281","volume":"8","author":"D Walsh","year":"2000","unstructured":"Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8(3):175\u2013179","journal-title":"Support Care Cancer"},{"issue":"1","key":"4623_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00520-016-3371-3","volume":"25","author":"D Walsh","year":"2017","unstructured":"Walsh D, Davis M, Ripamonti C, Bruera E, Davies A, Molassiotis A (2017) 2016 updated MASCC\/ESMO consensus recommendations: management of nausea and vomiting in advanced cancer. Support Care Cancer 25(1):333\u2013340","journal-title":"Support Care Cancer"},{"key":"4623_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2147\/CIA.S13109","volume":"6","author":"P Glare","year":"2011","unstructured":"Glare P, Miller J, Nikolova T, Tickoo R (2011) Treating nausea and vomiting in palliative care: a review. Clin Interv Aging 6:243\u2013259","journal-title":"Clin Interv Aging"},{"issue":"1","key":"4623_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejca.2005.06.022","volume":"42","author":"M Groenvold","year":"2006","unstructured":"Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hammerlid E, Kaasa S, Sprangers MA, Bjorner JB, EORTC Quality of Life Group (2006) The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42(1):55\u201364","journal-title":"Eur J Cancer"},{"key":"4623_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejca.2018.04.016","volume":"100","author":"MA Petersen","year":"2018","unstructured":"Petersen MA, Aaronson NK, Arraras JI, Chie WC, Conroy T, Costantini A, Dirven L, Fayers P, Gamper EM, Giesinger JM, Habets EJJ, Hammerlid E, Helbostad J, Hjermstad MJ, Holzner B, Johnson C, Kemmler G, King MT, Kaasa S, Loge JH, Reijneveld JC, Singer S, Taphoorn MJB, Thamsborg LH, Tomaszewski KA, Velikova G, Verdonck-de Leeuw IM, Young T, Groenvold M, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (2018) The EORTC CAT Core-the computer adaptive version of the EORTC QLQ-C30 questionnaire. Eur J Cancer 100:8\u201316","journal-title":"Eur J Cancer"},{"key":"4623_CR16","volume-title":"The EORTC QLQ-C30 scoring manual","author":"PM Fayers","year":"2001","unstructured":"Fayers PM, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. European organisation for research and treatment of cancer, Brussels","edition":"3"},{"key":"4623_CR17","volume-title":"Addendum to the EORTC QLQ-C30 scoring manual: scoring of the EORTC QLQ-C15-PAL","author":"M Groenvold","year":"2006","unstructured":"Groenvold M, Petersen MA (2006) Addendum to the EORTC QLQ-C30 scoring manual: scoring of the EORTC QLQ-C15-PAL. European organisation for research and treatment of cancer, Brussels"},{"issue":"4","key":"4623_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1191\/0269216303pm760oa","volume":"17","author":"J Potter","year":"2003","unstructured":"Potter J, Hami F, Bryan T, Quigley C (2003) Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med 17(4):310\u2013314","journal-title":"Palliat Med"},{"issue":"4","key":"4623_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/026921639500900404","volume":"9","author":"J Addington-Hall","year":"1995","unstructured":"Addington-Hall J, McCarthy M (1995) Dying from cancer: results of a national population-based investigation. Palliat Med 9(4):295\u2013305","journal-title":"Palliat Med"},{"issue":"9","key":"4623_CR20","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/0959-8049(94)90182-1","volume":"30a","author":"RK Portenoy","year":"1994","unstructured":"Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L (1994) The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30a(9):1326\u20131336","journal-title":"Eur J Cancer"},{"issue":"6","key":"4623_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0885-3924(97)00263-7","volume":"14","author":"C Conill","year":"1997","unstructured":"Conill C, Verger E, Henriquez I, Saiz N, Espier M, Lugo F et al (1997) Symptom prevalence in the last week of life. J Pain Symptom Manag 14(6):328\u2013331","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"4623_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00520-010-0865-2","volume":"19","author":"WY Cheung","year":"2011","unstructured":"Cheung WY, Le LW, Gagliese L, Zimmermann C (2011) Age and gender differences in symptom intensity and symptom clusters among patients with metastatic cancer. Support Care Cancer 19(3):417\u2013423","journal-title":"Support Care Cancer"},{"issue":"6","key":"4623_CR23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/cas.12146","volume":"104","author":"I Sekine","year":"2013","unstructured":"Sekine I, Segawa Y, Kubota K, Saeki T (2013) Risk factors of chemotherapy-induced nausea and vomiting: index for personalized antiemetic prophylaxis. Cancer Sci 104(6):711\u2013717","journal-title":"Cancer Sci"},{"issue":"10","key":"4623_CR24","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1054\/bjoc.2001.2116","volume":"85","author":"MS Jordhoy","year":"2001","unstructured":"Jordhoy MS, Fayers P, Loge JH, Saltnes T, Ahlner-Elmqvist M, Kaasa S (2001) Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics. Br J Cancer 85(10):1478\u20131485","journal-title":"Br J Cancer"},{"issue":"3","key":"4623_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jpainsymman.2013.10.027","volume":"48","author":"ST Dong","year":"2014","unstructured":"Dong ST, Butow PN, Costa DS, Lovell MR, Agar M (2014) Symptom clusters in patients with advanced cancer: a systematic review of observational studies. J Pain Symptom Manag 48(3):411\u2013450","journal-title":"J Pain Symptom Manag"},{"issue":"6","key":"4623_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1177\/0269216309105400","volume":"23","author":"AT Johnsen","year":"2009","unstructured":"Johnsen AT, Petersen MA, Pedersen L, Groenvold M (2009) Symptoms and problems in a nationally representative sample of advanced cancer patients. Palliat Med 23(6):491\u2013501","journal-title":"Palliat Med"},{"issue":"3","key":"4623_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.clon.2009.12.002","volume":"22","author":"L Jarlbaek","year":"2010","unstructured":"Jarlbaek L, Hansen DG, Bruera E, Andersen M (2010) Frequency of opioid use in a population of cancer patients during the trajectory of the disease. Clin Oncol (R Coll Radiol) 22(3):199\u2013207","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"4623_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/15360288.2014.938889","volume":"28","author":"SL Kane-Gill","year":"2014","unstructured":"Kane-Gill SL, Rubin EC, Smithburger PL, Buckley MS, Dasta JF (2014) The cost of opioid-related adverse drug events. J Pain Palliat Care Pharmacother 28(3):282\u2013293","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"4","key":"4623_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s00520-005-0897-1","volume":"14","author":"J Stephenson","year":"2006","unstructured":"Stephenson J, Davies A (2006) An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer 14(4):348\u2013353","journal-title":"Support Care Cancer"},{"issue":"3","key":"4623_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1191\/026921601678576239","volume":"15","author":"A Bentley","year":"2001","unstructured":"Bentley A, Boyd K (2001) Use of clinical pictures in the management of nausea and vomiting: a prospective audit. Palliat Med 15(3):247\u2013253","journal-title":"Palliat Med"},{"issue":"9","key":"4623_CR31","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1089\/jpm.2013.0610","volume":"17","author":"M Agar","year":"2014","unstructured":"To TH, Agar M, Yates P, Currow DC (2014) Prescribing for nausea in palliative care: a cross-sectional national survey of Australian palliative medicine doctors. J Palliat Med 17(9):1032\u20131036","journal-title":"J Palliat Med"},{"issue":"2","key":"4623_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1191\/0269216304pm852oa","volume":"18","author":"F Nauck","year":"2004","unstructured":"Nauck F, Ostgathe C, Klaschik E, Bausewein C, Fuchs M, Lindena G, Neuw\u00f6hner K, Schulenberg D, Radbruch L, Working Group on the Core Documentation for Palliative Care Units in Germany (2004) Drugs in palliative care: results from a representative survey in Germany. Palliat Med 18(2):100\u2013107","journal-title":"Palliat Med"},{"issue":"1","key":"4623_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/jpm.2012.0205","volume":"16","author":"O Lindqvist","year":"2013","unstructured":"Lindqvist O, Lundquist G, Dickman A, Bukki J, Lunder U, Hagelin CL et al (2013) Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion. J Palliat Med 16(1):38\u201343","journal-title":"J Palliat Med"},{"issue":"7","key":"4623_CR34","doi-asserted-by":"publisher","first-page":"883","DOI":"10.6004\/jnccn.2017.0117","volume":"15","author":"MJ Berger","year":"2017","unstructured":"Berger MJ, Ettinger DS, Aston J, Barbour S, Bergsbaken J, Bierman PJ, Brandt D, Dolan DE, Ellis G, Kim EJ, Kirkegaard S, Kloth DD, Lagman R, Lim D, Loprinzi C, Ma CX, Maurer V, Michaud LB, Nabell LM, Noonan K, Roeland E, Rugo HS, Schwartzberg LS, Scullion B, Timoney J, Todaro B, Urba SG, Shead DA, Hughes M (2017) NCCN guidelines insights: antiemesis, version 2.2017. J Natl Compr Cancer Netw 15(7):883\u2013893","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"4623_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00520-016-3313-0","volume":"25","author":"J Herrstedt","year":"2017","unstructured":"Herrstedt J, Roila F, Warr D, Celio L, Navari RM, Hesketh PJ, Chan A, Aapro MS (2017) 2016 updated MASCC\/ESMO consensus recommendations: prevention of nausea and vomiting following high emetic risk chemotherapy. Support Care Cancer 25(1):277\u2013288","journal-title":"Support Care Cancer"},{"key":"4623_CR36","unstructured":"Available from: \n                    http:\/\/pro.medicin.dk\/Generelt\/Nyheder\/222\n                    \n                  . Accessed Sep 2018"},{"issue":"2","key":"4623_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40261-015-0360-0","volume":"36","author":"N Leelakanok","year":"2016","unstructured":"Leelakanok N, Holcombe A, Schweizer ML (2016) Domperidone and risk of ventricular arrhythmia and cardiac death: a systematic review and meta-analysis. Clin Drug Investig 36(2):97\u2013107","journal-title":"Clin Drug Investig"},{"issue":"5","key":"4623_CR38","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/cncr.27854","volume":"119","author":"D Hui","year":"2013","unstructured":"Hui D, Glitza I, Chisholm G, Yennu S, Bruera E (2013) Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials. Cancer 119(5):1098\u20131105","journal-title":"Cancer"},{"issue":"1","key":"4623_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jpainsymman.2009.11.321","volume":"40","author":"JR Hardy","year":"2010","unstructured":"Hardy JR, O'Shea A, White C, Gilshenan K, Welch L, Douglas C (2010) The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer. J Pain Symptom Manag 40(1):111\u2013116","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"4623_CR40","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0885-3924(01)00420-1","volume":"23","author":"C Sinnott","year":"2002","unstructured":"Sinnott C (2002) Problems recruiting cancer patients to a comparative clinical trial of drug treatments for neuropathic pain in palliative care. J Pain Symptom Manag 23(4):270\u2013272","journal-title":"J Pain Symptom Manag"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4623-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-018-4623-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4623-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T19:05:09Z","timestamp":1578078309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-018-4623-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4623"],"URL":"https:\/\/doi.org\/10.1007\/s00520-018-4623-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]},"assertion":[{"value":"4 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}